Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$4.9 - $12.86 $4,302 - $11,291
-878 Reduced 2.25%
38,076 $456,000
Q3 2023

Nov 07, 2023

SELL
$7.0 - $11.26 $42,959 - $69,102
-6,137 Reduced 13.61%
38,954 $272,000
Q2 2023

Aug 04, 2023

SELL
$7.61 - $9.46 $51,923 - $64,545
-6,823 Reduced 13.14%
45,091 $383,000
Q1 2023

May 08, 2023

BUY
$8.83 - $17.61 $323,010 - $644,191
36,581 Added 238.58%
51,914 $474,000
Q4 2022

Feb 10, 2023

BUY
$10.88 - $20.05 $18,778 - $34,606
1,726 Added 12.68%
15,333 $174,000
Q3 2022

Nov 10, 2022

BUY
$16.06 - $26.39 $16,059 - $26,390
1,000 Added 7.93%
13,607 $232,000
Q2 2022

Aug 12, 2022

BUY
$20.49 - $39.72 $258,317 - $500,750
12,607 New
12,607 $271,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.26B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.